Real-world clinical experience with ruxolitinib cream versus systemic therapies in patients with moderate atopic dermatitis in the United States

Jinan Liu, Oliver Howell, James Piercy, Peter Anderson, Daniel Sturm

Open source

DOI
10.1080/09546634.2026.2698965
Published
2026-09-07
Container
Journal of Dermatological Treatment
Publisher
Informa UK Limited
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/09546634.2026.2698965,
  title = {Real-world clinical experience with ruxolitinib cream versus systemic therapies in patients with moderate atopic dermatitis in the United States},
  author = {Jinan Liu and Oliver Howell and James Piercy and Peter Anderson and Daniel Sturm},
  year = {2026},
  journal = {Journal of Dermatological Treatment},
  doi = {10.1080/09546634.2026.2698965},
  url = {https://doi.org/10.1080/09546634.2026.2698965}
}

RIS

TY  - JOUR
TI  - Real-world clinical experience with ruxolitinib cream versus systemic therapies in patients with moderate atopic dermatitis in the United States
AU  - Jinan Liu
AU  - Oliver Howell
AU  - James Piercy
AU  - Peter Anderson
AU  - Daniel Sturm
PY  - 2026
JO  - Journal of Dermatological Treatment
DO  - 10.1080/09546634.2026.2698965
UR  - https://doi.org/10.1080/09546634.2026.2698965
ER  - 

APA

Liu, J., Howell, O., Piercy, J., Anderson, P., & Sturm, D. (2026). Real-world clinical experience with ruxolitinib cream versus systemic therapies in patients with moderate atopic dermatitis in the United States. Journal of Dermatological Treatment. https://doi.org/10.1080/09546634.2026.2698965

Source records